SEATTLE, March 6, 2015 /PRNewswire/ -- CTI BioPharma
Corp. (NASDAQ and MTA: CTIC) announced today that its management
plans to host a conference call and webcast on Monday, March 9 at 8:00
a.m. EDT (5:00 a.m. PDT).
Access to the event can be obtained as follows:
Monday, March 9
5:00 a.m. PDT/8:00 a.m. EDT/1:00 p.m.
CET
1-888-471-3843 (domestic)
+1 719-325-2376 (international)
To access the live audio webcast or the subsequent archived
recording, visit CTI BioPharma's website, www.ctibiopharma.com.
Webcast and telephone replays of the conference call will be
available at approximately two hours after completion of the call.
Callers can access the replay by dialing 1-888-203-1112 (domestic)
or +1 719-457-0820 (international). The access code for the replay
is 1881293. The telephone replay will be available
until Monday, March 16, 2015.
About CTI BioPharma
CTI BioPharma Corp. (NASDAQ and MTA: CTIC) is a
biopharmaceutical company focused on the acquisition, development
and commercialization of novel targeted therapies covering a
spectrum of blood-related cancers that offer a unique benefit to
patients and healthcare providers. CTI BioPharma has a commercial
presence in Europe and a
late-stage development pipeline, including pacritinib, CTI
BioPharma's lead product candidate that is currently being studied
in a Phase 3 program for the treatment of patients with
myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington, with offices in
London and Milan under the name
CTI Life Sciences Limited. For additional information and to sign
up for email alerts and get RSS feeds, please visit
www.ctibiopharma.com.
Contacts:
Monique
Greer
+1 206-272-4343
mgreer@ctibiopharma.com
Ed Bell
+1 206-282-7100
ebell@ctibiopharma.com
In Europe: CTI Life Sciences Limited, Milan Branch
Laura Villa
+39 02 94751572
lvilla@cti-lifesciences.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cti-biopharma-to-host-conference-call-and-webcast-on-march-9-300046931.html
SOURCE CTI BioPharma Corp.